Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
1.500
-0.060 (-3.85%)
At close: Jan 30, 2025, 4:00 PM
1.490
-0.010 (-0.67%)
After-hours: Jan 30, 2025, 7:58 PM EST
Vincerx Pharma Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$2.00
Upside
+33.33%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Maintains $4 → $2 | Buy | Maintains | $4 → $2 | +33.33% | Oct 8, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $5 | Buy | Reiterates | $5 | +233.33% | Sep 7, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +100.00% | Nov 17, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +233.33% | Aug 12, 2022 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $22 → $8 | Buy | Maintains | $22 → $8 | +433.33% | Jun 8, 2022 |
B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $6 | Strong Buy | Maintains | $12 → $6 | +300.00% | Jun 7, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $4 | Strong Buy | Maintains | $11 → $4 | +166.67% | Jun 7, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $19 → $6 | Buy | Maintains | $19 → $6 | +300.00% | Jun 7, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $14 → $11 | Strong Buy | Maintains | $14 → $11 | +633.33% | May 13, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +1,166.67% | May 13, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +1,233.33% | Mar 30, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $28 | Strong Buy | Maintains | $25 → $28 | +1,766.67% | Mar 30, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +1,566.67% | Jan 14, 2022 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $25 | Buy | Initiates | $25 | +1,566.67% | Dec 23, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.